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Glucose degradation products in peritoneal dialysis fluids: Do buildup of glucose degradation products (GDP). Among
they harm? the products of glucose breakdown are 5-hydroxymeth-
Background. Severe limitations in biocompatibility of con- ylfuraldehyde (5-HMF) and 3,4-dideoxyglucosone-3-eneventional peritoneal dialysis fluids (PDF) can be partially at-
(3,4-DGE), which can be identified by typical increasestributed to the presence of glucose degradation products (GDP),
in ultraviolet absorbance at 284 nm and 228 nm, respec-which are generated during autoclaving of PDF. Formation of
GDP can be significantly reduced by the use of multi-chamber tively [1, 2]. The presence of other GDP can be visualized
bag systems. Recent clinical studies have revealed increased by high-performance liquid chromatography. However,
dialysate levels of pro-collagen I C-terminal peptide (PICP) in only a few of these products have been identified, mostly
patients dialyzed with these solutions. Here, we briefly review
as small molecular weight aldehydes (Table 1).the current knowledge on various aspects of GDP toxicity toward
While degradation of glucose is a clear consequenceperitoneal cells and analyze the impact of GDP on PICP release
by human peritoneal mesothelial cells (HPMC) in vitro. of autoclaving, the presence of GDP in PDF sterilized
Methods. HPMC were exposed to a mixture of known GDP by filtration is negligible. Therefore, the biological effects
added to culture medium at clinically relevant doses. After 12 exerted by GDP can be deduced from experiments that
days, the amount of PICP released was measured using an
compare the function of cells treated with PDF sterilizedimmunoassay. Furthermore, the protein synthesis was assessed
either by heat or by filtration. Several studies that em-by 3H-proline incorporation in HPMC exposed to peritoneal
effluent obtained from patients after three months of CAPD ployed such an approach have revealed that heat-steri-
with either conventional PDF or low-GDP solution. lized solutions compromise cell functions to a signifi-
Results. Exposure to GDP resulted in a significant decrease cantly greater extent than filter-sterilized solutions [3].
in PICP release by HPMC. In addition, the synthesis of new
The puzzling effect observed in these studies was thatproteins secreted by HPMC was preserved significantly better
six GDP identified at that time (acetaldehyde, formalde-in HPMC treated with effluent obtained when patients were
dialyzed with low-GDP solutions rather than conventional PDF. hyde, 2-furaldehyde, glyoxal, 5-hydroxymethylfuralde-
Conclusions. Exposure to GDP may impair protein synthe- hyde, and methylglyoxal) produced inhibitory effects
sis and secretion by HPMC. Therefore, increased dialysate only at doses far exceeding those present in PDF, while
PICP levels in response to GDP-free PDF may be viewed as
the GDP at clinically relevant concentrations remainedevidence of improved mesothelial cell function.
relatively harmless. Moreover, the addition of these GDP
to filter-sterilized PDF did not increase their toxicity to
the level displayed by heat-sterilized PDF. Since theseTOXICITY OF GLUCOSE DEGRADATION
early studies examined only short-term effects of GDPPRODUCTS IN VITRO
exposure, we have established a model in which human
Breakdown of glucose contained in peritoneal dialysis peritoneal mesothelial cells (HPMC) could be maintained
fluids (PDF) results primarily from exposure to heat in culture and exposed to GDP for as long as six weeks.
during autoclaving. Spontaneous decomposition of glu- Using this model, we have found that the six identified
cose at room temperatures is much less intense, although aldehydes at low doses that were not overtly toxic during
prolonged storage of PDF may also lead to a significant short-term exposure significantly impaired viability and
function of HPMC during prolonged incubation [4]. This
was an important observation given the chronic natureKey words: glucose degradation products, peritoneal dialysis fluids,
biocompatibility, peritoneal mesothelial cells. of CAPD treatment.
Although the GDP responsible for acute toxicity of 2003 by the International Society of Nephrology
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Table 1. Glucose degradation products identified in peritoneal dialysis solutions
Molecular weight Concentration
GDP g/mol lM Reference
Acetaldehyde 44.05 120–420 1993; Nilsson Thorell [1]
Formaldehyde 30.03 6–15 1993; Nilsson Thorell [1]
2-furaldehyde 96.08 0.05–2 1993; Nilsson Thorell [1]
Glyoxal 58.04 3–14 1993; Nilsson Thorell [1]
5-hydroxymethylfuraldehyde 126.1 6–30 1993; Nilsson Thorell [1]
Methylglyoxal 72.06 2–23 1993; Nilsson Thorell [1]
Valeraldehyde 86.13 n.d. 1993; Nilsson Thorell [1]
3-deoxyglucosone 162.14 118–154 1998, Linden [19]
3,4-dideoxyglucosone-3-ene 144.12 9–22 2002; Linden [2]
GDP is glucose degradation product.
heat-sterilized PDF remain obscure, recent identification PDF, since this procedure eliminates, to a great extent,
of further GDP in PDF may shed new light on this phe- the breakdown of glucose during autoclaving [11]. The
nomenon. While 3-DG does not appear to acutely inhibit strategy that can provide PDF low in GDP, but neutral
cell function [abstract; Bender et al, Perit Dial Int 21:S12, in pH, is based on compartmentalization of PDF bags. In
2001], the impact of 3,4-DGE may be far more serious. novel multi-chamber PDF systems, highly concentrated
Using a previously established system that measures the glucose at pH as low as 2.8–3.0 is separated from an
inhibition of L929 fibroblast proliferation, Linden et al alkaline electrolyte/buffer solution during heat-steriliza-
[2] have recently reported that 3,4-DGE is the only GDP tion [11]. Immediately prior to use, the solutions from
identified so far that displays significant acute cytotoxic- both compartments are mixed together and as a result,
ity at doses actually found in PDF. one receives pH-neutral, low-GDP solution to infuse
These in vitro findings gain further support from ani- into the peritoneal cavity. An additional advantage of
mal studies. Peritoneal macrophages isolated from rats multi-chamber systems is that they allow the use of bicar-
injected with heat-sterilized fluids displayed reduced bonate as a buffer by eliminating its precipitation.
ability to mount a respiratory burst compared with cells Clinical trials and ex vivo studies appear to corrobo-
isolated from animals treated with filter-sterilized PDF rate the potential benefits of these novel solutions. The
[5]. More recently, it has been demonstrated that heat- function of peritoneal macrophages was found to be bet-
sterilized PDF induce significant changes in peritoneal ter preserved in patients continuously exposed to dual-
hemodynamics and microcirculation in rats, and these chambered PDF buffered with either bicarbonate and
effects are much less pronounced in response to PDF lactate, or bicarbonate alone [12, 13]. On the other hand,
with low GDP content [6]. the outbreak of chemical peritonitis associated with se-
vere abdominal discomfort was reported in patients who
received a batch of PDF contaminated with high levelsGLUCOSE DEGRADATION PRODUCTS AND
of acetaldehyde [14]. In this respect, new PDF appearAGES FORMATION
to be well tolerated and alleviate the inflow pain [15].It has been observed that accumulation of advanced
glycation end products (AGEs) in the peritoneum corre-
lates with impaired peritoneal permeability [7, 8]. Forma- DIALYSATE MARKERS
tion of peritoneal AGEs has been commonly viewed as a OF BIOCOMPATIBILITY
consequence of prolonged exposure to elevated glucose;
Therapy with new PDF was found to increase CA125
however, increasing evidence indicate that certain GDP
and decrease hyaluronan levels in the peritoneal cavity(methylglyoxal and 3-deoxyglucosone, in particular) are
[15, 16]. CA125 is viewed as a marker of mesothelial celleven more potent inducers of AGEs than glucose itself
integrity, while hyaluronic acid has been suggested as a[9]. Indeed, it has been demonstrated that heat sterilized-
marker of inflammation and tissue remodeling. Thus,PDF significantly exacerbate in vitro formation of AGEs
reduced hyaluronan levels may reflect less irritation to thecompared with filter-sterilized PDF of equal glucose con-
peritoneum, and elevated CA125 may represent improvedcentration [10].
growth and regeneration of HPMC. In this respect, pre-
liminary data indicate that compared with conventional
BENEFITS OF MULTI-CHAMBER PDF, the solutions containing less GDP improve meso-
DIALYSIS SYSTEMS thelial healing following in vitro wounding and the process
is associated with increased CA125 expression [abstract;The unfavorable effects associated with GDP could
be considerably reduced by drastically lowering pH in Morgan et al, Perit Dial Int 22:103, 2002]. Furthermore,
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Fig. 2. Effect of peritoneal effluent on mesothelial cell protein synthe-
sis. HPMC were exposed for 48 hours to spent dialysate mixed with an
equal volume of M199 serum-free culture medium, supplemented with
-aminopropionitrile and ascorbic acid (both at 50 g/mL) and labeled
with 4 Ci/ml of 3H-proline. Timed (10-hour) effluent was obtained
Fig. 1. Effect of GDP on PICP release of PICP from mesothelial cells. from 17 patients after three months of CAPD with either conventional
HPMC were incubated in M199 culture medium supplemented with a solution (S-PDF) or new low-GDP fluid (Balance). The radioactivity
mixture of GDP at doses found in PDF (M): acetaldehyde – 420; incorporated into cell-associated (left) and -secreted (right) proteins
formaldehyde – 15; furaldehyde – 2; glyoxal – 14; methylglyoxal – 23; was released and measured in a-liquid scintillation counter. The results
5-hydroxymethylfuraldehyde – 30 mM. After 12 days of exposure, the were analyzed using the Wilcoxon test for paired nonparametric data
release of PICP over the period of the last 24 hours was measured and are presented as box and whisker plots that represent the median,
using a Prolagen-C kit (Metra-Biosystem, Osnabru¨ck, Germany) with 25th, and 75th percentiles, and the range of the data.
sensitivity of 0.2 ng/mL. The results were analyzed using the Wilcoxon
test for paired nonparametric data and are presented as mean ( SD)
from seven experiments with HPMC from separate donors.
viability [4]. Furthermore, we have examined the impact
on HPMC protein synthesis of peritoneal effluent ob-
tained from patients participating in the Euro Balancecollagen IV that forms a submesothelial basement mem-
Trial. During this randomized, controlled, crossover study,brane was reported to be less glycated following expo-
the patients were treated sequentially for three monthssure to low GDP solution, and supported HPMC prolif-
with either conventional solution (S-PDF) or a new pH-eration better than a matrix treated with conventional
neutral low-GDP solution (Balance; Fresenius MedicalPDF [abstract; Jones et al, Perit Dial Int 22:102, 2002].
Care, Bad Homburg, Germany). The dialysate was drainedInconsistent results were obtained regarding intraperi-
after a timed (10-hour) dwell and added to vitro culturestoneal levels of pro-collagen I C-terminal peptide (PICP).
of HPMC. The rate of protein synthesis was measuredRippe et al [15] reported on increased levels of dialysate
by 3H-proline incorporation. We have found that thePICP during dialysis with low GDP solution buffered
amount of newly synthesized proteins in cell-associatedwith lactate. In contrast, Jones et al [16] did not observe
material in HPMC exposed to S-PDF effluent was nottime-dependent changes in PICP levels in patients re-
different from that detected in Balance-treated cells.
ceiving PDF low in GDP and buffered with a mixture
However, the secretion of new proteins was increased
of lactate and bicarbonate. Increased levels of PICP may in cultures treated with Balance compared to S-PDF
be regarded as an indicator of ongoing fibrosis; however, (Fig. 2). These data indicate that exposure to GDP may
they may also be viewed as a simple consequence of suppress protein turnover in HPMC.
improved cell function and enhanced protein turnover.
FUTURE PROSPECTS
EFFECT OF GLUCOSE DEGRADATION
While new multi-chambered PDF systems appear toPRODUCTS ON MESOTHELIAL CELL
offer an immediate improvement in PDF biocompatibil-PROTEIN SYNTHESIS
ity, other options are also under consideration. It has
We have assessed the rate of protein synthesis in been demonstrated that aminoguanidine or OPB-9195
HPMC treated in vitro with GDP or GDP-containing may trap and reduce GDP levels in PDF [17, 18]. Fur-
dialysate. HPMC were chronically exposed to a mixture thermore, the levels of glyoxal and methylglyoxal can
of known GDP at concentrations found in PDF, as de- be lowered by the addition of glyoxalase and glutathione,
scribed previously [4]. We found that following a 12-day which metabolize carbonyl compounds. In this respect,
incubation in the presence of GDP, the release of PICP it has been suggested that gene therapy may increase
from HPMC was reduced by (mean SD, N 7) 72.3% availability of glyoxalase in the peritoneum [17]. It re-
20.5% compared to control cells (Fig. 1). This decrease mains to be determined if these approaches prove clini-
cally useful.in PICP secretion paralleled the gradual decline in cell
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